Cintas Corporation Announces Fiscal 2022 Third Quarter Results

Go back to Cintas Corporation Announces Fiscal 2022 Third Quarter Results

Cintas (CTAS) PT Raised to $493 at Goldman Sachs, Keeps Top Rating

March 23, 2022 3:49 PM EDT

Goldman Sachs analyst George Tong raised the price target on Cintas (NASDAQ: CTAS) to $493.00 (from $460.00) while maintaining a Conviction Buy rating.

"Revenue tailwinds from healthcare vertical, with pricing and technology efficiencies bolstering margins"... More

CFRA Upgrades Cintas (CTAS) to Hold

March 23, 2022 11:37 AM EDT

CFRA upgraded Cintas (NASDAQ: CTAS) from Sell to Hold with a price target of $403.00 (from $364.00).

For an analyst ratings summary and ratings history on Cintas click here. For more ratings news on Cintas click here.

Shares of Cintas closed at $393.00 yesterday.

... More

Cintas Corp. (CTAS) Tops Q3 EPS by 55c, Offers Guidance

March 23, 2022 8:33 AM EDT

Cintas Corp. (NASDAQ: CTAS) reported Q3 EPS of $2.97, $0.55 better than the analyst estimate of $2.42. Revenue for the quarter came in at $1.96 billion versus the consensus estimate of $1.9 billion.

GUIDANCE:

Cintas Corp. sees Q4 2022 EPS of $2.54-$2.74, versus the consensus of... More